POP-OUT | CLOSE
 
 
RETINOIC ACID
 
REA is found in 31 entries
REA
  •   Chemical Component Summary   Hide
    Name RETINOIC ACID
    Identifiers (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid
    Formula C20 H28 O2
    Molecular Weight 300.44 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key SHGAZHPCJJPHSC-YCNIQYBTSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00982   (Different stereochemistry)
    Name Isotretinoin
    Groups approved
    Description Isotretinoin is a medication used for the treatment of severe acne. It is sometimes used in prevention of certain skin cancers. It is a retinoid, meaning it derives from vitamin A and is found in small quantities naturally in the body. Isotretinoin binds to and activates nuclear retinoic acid receptors (RAR), thereby regulating cell proliferation and differentiation. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.
    Brand names Accutane Roche
    Affected organism Humans and other mammals
    Indication For the treatment of severe recalcitrant nodular acne
    Pharmacology Isotretinoin, a retinoid, is indicated in the treatment of severe recalcitrant nodular acne. Nodules are inflammatory lesions with a diameter of 5 mm or greater. The nodules may become suppurative or hemorrhagic. "Severe," by definition, means "many" as opposed to "few or several" nodules. Clinical improvement in nodular acne patients occurs in association with a reduction in sebum secretion. The decrease in sebum secretion is temporary and is related to the dose and duration of treatment with Accutane, and reflects a reduction in sebaceous gland size and an inhibition of sebaceous gland differentiation.
    Mechanism of action Isotretinoin noticeably reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones from forming. It also reduces inflammation in moderate-severe inflammatory acne. The exact mechanism of action is unknown, however it is known that it alters DNA transcription.
    Route of administration Oral
    Categories
    • Antineoplastic Agents
    • Anti-acne Agents
    • Keratolytic Agents
    • Skin and Mucous Membrane Agents
    ATC-Code
    • D10AD04
    • D10BA01
    AHFS-Code 84:92.00
    CAS number 4759-48-2
    Targets
    Name Sequence search Pharmacological action Actions
    Retinoic acid receptor alpha   Search  unknown other/unknown
     
Ligand Image